BRAF and neoplasm: Mechanisms of RAI resistance include genetic mutations (e.g., BRAF V600E mutation, TERT promoter mutation), dysfunction of iodine-transporting proteins (e.g., NIS), and disturbances in the tumor microenvironment (TME).